Live Update 
From the Liveblog of
Thursday, June 11, 2020
From the Liveblog of
Thursday, June 11, 2020
Biotech firm Regeneron starts trials for coronavirus antibody treatment
Add ToI as a Preferred Source on GoogleUS biotech firm Regeneron Pharmaceuticals is the latest company to start clinical trials on a potential treatment for coronavirus, using antibodies produced by those who have recovered from COVID-19.
The treatment uses a combination of two antibodies to treat those sick with the virus and as a preventive measure to help inoculate those still healthy.
“We have created a unique anti-viral antibody cocktail with the potential both to prevent and treat infection,” the company’s chief scientific officer George Yancopoulos says in a statement.
Regeneron does not give a timetable for when it believes tests will be completed.
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here